How should a purulent facial rash with pustules over the lips (impetigo) be treated?

Treatment of Purulent Facial Rash with Pustules Over Lips (Impetigo)

For impetigo with pustules over the lips, topical mupirocin or retapamulin should be used as first-line treatment for localized disease, while oral antibiotics (penicillinase-resistant penicillin, first-generation cephalosporins, or clindamycin) are reserved for extensive lesions or when topical therapy is impractical. 1

Classification and Treatment Selection

The key decision point is determining whether the impetigo is localized (fewer than 10 lesions and smaller than 36 cm² total area) versus widespread. 2

For Localized Disease (Most Cases)

• Topical antibiotics are as effective as oral antimicrobials and should be preferred to minimize systemic antibiotic exposure and support antimicrobial stewardship. 1

• First-line topical options include:

  • Mupirocin (highly effective, well-studied) 1, 3
  • Retapamulin (equally effective, no resistance reported yet) 3, 4
  • Fusidic acid where available (equivalent efficacy to mupirocin) 3, 4

• Topical antibiotics demonstrated superior cure rates compared to placebo (RR 2.24,95% CI 1.61-3.13). 3

For Widespread or Extensive Disease

When patients present with numerous lesions or in outbreak settings, systemic therapy is preferred to decrease transmission. 1

• First-line oral antibiotics (targeting both S. aureus and streptococci unless culture shows streptococci alone):

  • Penicillinase-resistant penicillin (e.g., dicloxacillin) 1
  • First-generation cephalosporins (e.g., cephalexin) 1, 4
  • These are effective as most staphylococcal isolates from impetigo are methicillin-susceptible 1

• For penicillin-allergic patients or suspected MRSA:

  • Clindamycin 1, 4
  • Doxycycline (avoid in children <8 years) 1
  • Trimethoprim-sulfamethoxazole (covers MRSA but inadequate for streptococcal infection alone) 1, 4

• Avoid penicillin alone as it was inferior to erythromycin (RR 1.29,95% CI 1.07-1.56) and cloxacillin (RR 1.59,95% CI 1.21-2.08). 3

Important Clinical Considerations

Microbiological Coverage

• Empiric therapy must cover both S. aureus and β-hemolytic streptococci unless cultures demonstrate streptococci alone. 1

• If cultures yield streptococci alone, penicillin becomes the drug of choice, with macrolides or clindamycin as alternatives for penicillin-allergic patients. 1

Antimicrobial Resistance Patterns

• Know your local resistance patterns before prescribing, as resistance to mupirocin, fusidic acid, macrolides, and methicillin-resistant S. aureus (MRSA) has been widely reported. 2, 5, 4

• Newer agents like ozenoxacin cream 1% show high efficacy against both methicillin-susceptible and resistant S. aureus strains and may be suitable for localized impetigo. 2

Topical vs. Oral Comparison

• Topical mupirocin was slightly superior to oral erythromycin (pooled RR 1.07,95% CI 1.01-1.13) in 10 studies with 581 participants. 3

• There were no significant differences in cure rates between topical antibiotics and other oral antibiotics overall. 3

• Side effects were more common with oral antibiotics, primarily gastrointestinal effects. 3

Common Pitfalls to Avoid

• Do not use topical disinfectants as primary treatment—they are inferior to antibiotics (RR 1.15,95% CI 1.01-1.32 favoring topical antibiotics). 3

• Do not prescribe penicillin alone for empiric treatment of impetigo, as it is inadequate against S. aureus. 3

• Avoid trimethoprim-sulfamethoxazole monotherapy if streptococcal infection is suspected, as it provides inadequate streptococcal coverage. 4

• Be aware that patients may have already used expired antibiotics at home before presentation, which can complicate treatment response. 6

When to Consider Cultures

• Cultures of vesicle fluid, pus, or erosions can establish the causative organism and guide targeted therapy. 1

• While cultures are helpful, treatment without cultures is reasonable in typical cases to avoid delays. 1